Mackay Shields LLC reduced its holdings in shares of The Clorox Company (NYSE:CLX – Get Rating) by 3.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,412 shares of the company’s stock after selling 666 shares during the period. Mackay Shields LLC’s holdings in Clorox were worth $3,210,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in the business. Martin Capital Partners LLC increased its stake in shares of Clorox by 1.9% in the fourth quarter. Martin Capital Partners LLC now owns 3,022 shares of the company’s stock worth $527,000 after purchasing an additional 57 shares in the last quarter. Strategy Asset Managers LLC increased its stake in shares of Clorox by 3.6% in the third quarter. Strategy Asset Managers LLC now owns 1,670 shares of the company’s stock worth $277,000 after purchasing an additional 58 shares in the last quarter. Corient Capital Partners LLC increased its stake in shares of Clorox by 4.4% in the third quarter. Corient Capital Partners LLC now owns 1,585 shares of the company’s stock worth $262,000 after purchasing an additional 67 shares in the last quarter. Associated Banc Corp increased its stake in shares of Clorox by 4.9% in the third quarter. Associated Banc Corp now owns 1,469 shares of the company’s stock worth $243,000 after purchasing an additional 69 shares in the last quarter. Finally, Platform Technology Partners increased its stake in shares of Clorox by 2.2% in the third quarter. Platform Technology Partners now owns 3,557 shares of the company’s stock worth $589,000 after purchasing an additional 76 shares in the last quarter. 77.34% of the stock is owned by institutional investors and hedge funds.
CLX has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Clorox from $148.00 to $146.00 in a research note on Monday. JPMorgan Chase & Co. raised their target price on shares of Clorox from $123.00 to $126.00 in a research note on Thursday. Credit Suisse Group cut their target price on shares of Clorox from $160.00 to $155.00 and set an “underperform” rating for the company in a research note on Friday, February 4th. UBS Group cut their target price on shares of Clorox from $163.00 to $148.00 and set a “sell” rating for the company in a research note on Friday, February 4th. Finally, Wells Fargo & Company cut their target price on shares of Clorox from $150.00 to $120.00 and set an “underweight” rating for the company in a research note on Tuesday, March 15th. Ten research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Sell” and a consensus target price of $148.38.
Clorox (NYSE:CLX – Get Rating) last released its earnings results on Thursday, February 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.78 by ($0.12). The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. Clorox had a return on equity of 86.36% and a net margin of 3.49%. During the same quarter last year, the business posted $2.03 EPS. As a group, sell-side analysts predict that The Clorox Company will post 4.24 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, May 13th. Stockholders of record on Wednesday, April 27th will be issued a $1.16 dividend. The ex-dividend date is Tuesday, April 26th. This represents a $4.64 annualized dividend and a dividend yield of 3.19%. Clorox’s dividend payout ratio (DPR) is presently 233.17%.
Clorox Company Profile (Get Rating)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Tapestry Stock is a Value Play Down Here
- Levi Straus Stock Ready to Buy the Dip
- Bed Bath & Beyond Stock Ready to Scale Into
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.